Nous utilisons des cookies sur ce site pour analyser son utilisation et améliorer votre expérience utilisateur. Si vous êtes d'accord, veuillez cliquer sur "Accepter". Si vous souhaitez sélectionner individuellement les cookies que nous pouvons utiliser, modifier vos paramètres ou recevoir des informations plus détaillées, veuillez cliquer sur "Plus d'informations". Retrouvez toutes les informations sur la protection de vos données en cliquant ici. Informations sur la protection de vos données Plus d’informations Accepter LOGIN VETERINARY HURRY CONTACT WORLD SITE Search The Boehringer Ingelheim partnerships Our R&D strategy is based on open innovation in the form of external collaborations of 3 types: bilateral agreements with university researchers and biotechnology companies, public-private partnerships and the support of crowdsourcing initiatives. The partnership is an integral part of the group's strategy and contributes to the discovery of new drugs as well as to development efforts. Partnering Day Prescription drugs BioXcellence ™ Animal health Investment fund IMP IMB The mission of Boehringer Ingelheim Venture Fund is to invest in the development of new sciences, from idea to proof of concept. The Venture Fund is currently investing in a portfolio of 16 different start-ups with exciting new therapeutic ideas. Boehringer Ingelheim Venture Fund Vision INVESTMENT FUND Boehringer Ingelheim Investment Fund Opportunities to discover Home:PartnershipsInvestment fundInvestment fund Innovation Strategy R&D program BI France clinical research Clinical tests Prescription Cardiovascular Metabolic diseases Our products Activities Animal health Biomedicines Subsidiary sites To share Top of page Accessibility Terms of Service Personal data Cookies © 2010-2021 Boehringer Ingelheim France SAS - 16-0785. - All rights reserved